Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
March 24, 2018
Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women
André Dallmann, Juri Solodenko, Ibrahim Ince, et al.
Clinical Pharmacokinetics
|
September 20, 2017
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways
André Dallmann, Ibrahim Ince, Katrin Coboeken, et al.
The AAPS Journal
|
August 24, 2022
Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding
Heino Stass, Ibrahim Ince, Ulrike Grossmann, et al.
Clinical Pharmacokinetics
|
April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy
André Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery
André Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Clinical Pharmacokinetics
|
March 7, 2013
Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations
Ibrahim Ince, Catherijne A J Knibbe, Meindert Danhof, et al.
Clinical Pharmacokinetics
|
April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women
André Dallmann, Ibrahim Ince, Juri Solodenko, et al.
Drug Discovery Today
|
December 9, 2008
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling
Ibrahim Ince, Saskia N de Wildt, Dick Tibboel, et al.
Pharmaceutics
|
March 27, 2025
Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption
Tobias Kanacher, Erik Sjögren, Julia Korell, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2026
Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling
Marylore Chenel, Andre Dallmann, Ibrahim Ince, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
CPT: Pharmacometrics & Systems Pharmacology
|
March 24, 2018
Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women
André Dallmann, Juri Solodenko, Ibrahim Ince, et al.
Clinical Pharmacokinetics
|
September 20, 2017
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways
André Dallmann, Ibrahim Ince, Katrin Coboeken, et al.
The AAPS Journal
|
August 24, 2022
Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding
Heino Stass, Ibrahim Ince, Ulrike Grossmann, et al.
Clinical Pharmacokinetics
|
April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy
André Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery
André Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Clinical Pharmacokinetics
|
March 7, 2013
Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations
Ibrahim Ince, Catherijne A J Knibbe, Meindert Danhof, et al.
Clinical Pharmacokinetics
|
April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women
André Dallmann, Ibrahim Ince, Juri Solodenko, et al.
Drug Discovery Today
|
December 9, 2008
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling
Ibrahim Ince, Saskia N de Wildt, Dick Tibboel, et al.
Pharmaceutics
|
March 27, 2025
Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption
Tobias Kanacher, Erik Sjögren, Julia Korell, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 4, 2026
Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling
Marylore Chenel, Andre Dallmann, Ibrahim Ince, et al.
Page
of 3